CHARACTERISTICS OF FILGOTINIB-TREATED PATIENTS WITH ULCERATIVE COLITIS WHO ACHIEVE SUSTAINED CORTICOSTEROID-FREE REMISSION: POST HOC ANALYSIS OF THE PHASE 2B/3 SELECTION STUDY
Taku Kobayashi 1
Axel Dignass 2
Xavier Roblin 3
Yasushi Fujitani 4
Alessandra Oortwijn 5
Corinne Jamoul 6
Toshifumi Hibi 6
1 Kitasato University Kitasato Institute Hospital, Tokyo, Japan
2 Agaplesion Markus Krankenhaus, Frankfurt/ Main, Germany
3 University Hospital of Saint-Étienne, Saint-Étienne, France
4 Gilead Sciences K.K., Tokyo, Japan
5 Galapagos NV, Leiden, Netherlands
6 Galapagos NV, Mechelen, Belgium
Topic
IBD
Conference
UEG Week 2023
Citation
United European Gastroenterology Journal 2023; 11 (Supplement 8)
Login to access library content
Do you need help setting up your myUEG account?
Contact us at [email protected]